PharmaMedic /
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
PharmaMedic
  • Home
  • Our Services
    • Start-Up
    • Product Launch
    • Product Development
  • Join Us
  • About Us
    • Our Vision
    • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us

#marketaccess

Tag

EMA annual report reviews actions in 2022

EMA annual report reviews actions in 2022

The European Medicines Agency (EMA) has published its annual report for 2022, highlighting its challenges and successes in a year that saw it face ongoing and new public health emergencies.

24 May 2023
Read More
Will ABPI’s ambitious VPAG plans succeed VPAS?

Will ABPI’s ambitious VPAG plans succeed VPAS?

Discussions are beginning on the next iteration of the UK’s voluntary scheme for branded medicines, pricing and access (VPAS) and the Association of the British Pharmaceutical Industry (ABPI) has set out its stall to government. It has published a four-point proposal for a Voluntary Scheme for Pricing, Access and Growth (VPAG), designed to reignite competitiveness and boost innovation in the life sciences sector, thereby improving health outcomes and the wider economy.

15 May 2023
Read More
EC’s plans for updating pharma legislation unveiled

EC’s plans for updating pharma legislation unveiled

The European Commission’s (EC) long-awaited proposals for reforming pharma legislation have been published. The main thrust of the proposals is to create a single EU market for medicines to replace existing fragmentation and improve access for EU citizens.

11 May 2023
Read More
NICE extends international collaboration to streamline processes

NICE extends international collaboration to streamline processes

The UK’s National Institute for health and Care Excellence (NICE) has announced that it will be working closely with the Canadian Agency for Drugs and Technologies in Health (CADTH) and the US Institute for Clinical and Economic Review (ICER) to find common ground and smooth processes around the handling of confidential information about health technologies.

4 May 2023
Read More
BIA calls on NICE to update evidence on rare disease medicines

BIA calls on NICE to update evidence on rare disease medicines

New research has found that the public believes a new approach should be adopted for making funding decisions about treatments for rare diseases. The report ‘Rare insights: examining the social values of treating rare diseases’, was commissioned by the UK BioIndustry Association’s (BIA) Rare Disease Industry Group (RDIG).

20 Apr 2023
Read More
EFPIA Director General calls for action on pharma legislation

EFPIA Director General calls for action on pharma legislation

The head of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Nathalie Moll, has outlined two urgent actions that European pharma needs as the announcement of the EU’s pharma strategy has been postponed again by the European Commission.

11 Apr 2023
Read More
OHE Innovation Policy Prize

OHE Innovation Policy Prize

The Office of Health Economics (OHE) launched a biennial competition in early 2022 to answer the question ‘How can policymakers design a system to generate fair prices that balances access and innovation throughout the lifecycle of medicines?’ Join the live online ceremony on 24 January 2023.

5 Jan 2023
Read More
ABPI asks UK government to review VPAS as clawback will hit 26.5% of sales revenue in 2023

ABPI asks UK government to review VPAS as clawback will hit 26.5% of sales revenue in 2023

In 2023 manufacturers of branded medicines will be required to return almost £3.3bn in sales revenue to the government under the 2019 Voluntary scheme for branded medicines, pricing and access (VPAS), according to the Association of the British Pharmaceutical Industry (ABPI).

20 Dec 2022
Read More
ATMPs for rare diseases a priority for Innovative Health Initiative funding

ATMPs for rare diseases a priority for Innovative Health Initiative funding

Research themes under consideration for the next round of Innovative Health Initiative (IHI) funding include Topic 4: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases.

5 Dec 2022
Read More

Categories

  • Awards
  • Consultants
  • Events
  • News
    • General
    • Medical Affairs
    • Rare diseases
  • Our Services
  • Regulatory
  • Resources
    • White Paper

Tags

#ABPI #BIA #cancer #ClinicalTrials #diagnostics #drugdevelopment #drugpricing #drugregulation #EC #EFPIA #EMA #EU #FDA #HTA #innovation #lifesciences #marketaccess #MDR #medicaldevice #medicaldeviceregulation #medicinesaccess #mentalhealth #mhra #NHS #NICE #pharmaregulation #pre-eclampsia #R&D #rarediseaseresearch #rarediseases #regulation #regulatory #research #UKgovernment #ukregulation #VPAS AI Biotech COVID-19 Healthcare IR35 Medical Affairs medicaldevices Pharma UKmedicines
PharmaMedic
  • Home
  • Join Us
  • Our Vision
  • Dr Malcolm Barratt-Johnson
  • Resources
  • News
  • Contact Us
Our Services
  • Start-Up
  • Product Launch
  • Product Development
Legal
  • Privacy Policy
  • Cookie Policy
Contact us
  • T:+44 (0) 208 168 1668
  • US Toll Free:+1 628 201 0911
  • [javascript protected email address]
  • The London Bioscience Innovation Centre (LBIC)
    2 Royal College Street
    London NW1 0NH

©2023 PharmaMedic. All Rights Reserved | Company Registration Number: 07364364 | VAT: 135986768

Powered by FL1 Digital